(1)-1.png?width=520&name=GCAL%20Web%20805x403%20(1610%20x%20806%20px)(1)-1.png)
GCAL® Customer Interview: Calprotectin in routine care across departments
From laboratory integration to clinical impact at Motol University Hospital Inflammation is rarely..
Read more.jpg?width=520&name=GCAL%20Web%20805x403%20(1610%20x%20806%20px).jpg)
GCAL® Customer Story - 24/7 calprotectin testing in acute and chronic care
Enabling 24/7 circulating calprotectin testing in clinical practice
Read more
Calprotectin as a biomarker for immune dysfunction and 28‑day mortality in sepsis
Circulating calprotectin: biomarker of immune dysfunction in sepsis - study results Results from a post-hoc..
Read more.jpg?width=520&name=social%20media%20805x403(3).jpg)
Join our team: Territory Account Manager - Nordics
Are you our new Territory Account Manager in the Nordics? In this role, you will take full ownership of key..
Read more
Calprotectin supports risk stratification and monitoring in Anakinra-treated pneumonia
Calprotectin supports risk stratification and treatment monitoring in pneumonia patients receiving Anakinra..
Read more
Kidney Health for All – Caring for People, Protecting the Planet
Every year, World Kidney Day serves as a global reminder of the importance of kidney health. Chronic kidney..
Read more
Canine CRP customer story - Versatile biomarker for both acute and chronic conditions
Canine CRP customer story: Department of Clinical Veterinary Medicine at the University of Bern In the..
Read more
Webinar: Beyond creatinine: Why it’s time to integrate cystatin C into clinical practice
Time to integrate cystatin C into clinical practice Webinar | March 25th, 2026 | 09:00 AM PT | 12:00 PM ET |..
Read more
See you at "Lederdagene 2026" - Nordic event
Meet Gentian at "Lederdagene 2026" Gentian Diagnostics look forward to attend NITO Lederdagene 4th-5th March...
Read more
Canine CRP customer story - First-line test to detect inflammation
Gentian Canine CRP continuously available since 2013 The Gentian Canine CRP immunoassay, available since..
Read more